semaglutide psoriatic arthritis GLP-1 receptor agonists: emerging therapeutic potential in psoriasis management — current evidence and future outlook | European Journal of Clinical Pharmacology Microdosing Ozempic for Psoriatic Arthritis:

238.Craig H., Sharib J.R., Ridberg R., Caldwell J., Shah-Patel D., Warner K., Brown M., Chao C., Nau C., Schwartz P., et al

The New England Journal of Medicine series "Double Takes" is a new video series that explores medical topics, providing patient perspectives as well as scientific and clinical background

Cardiovascular Benefits: Research suggests that semaglutide may also offer cardiovascular benefits, including a reduced risk of major adverse cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease

In one study, Joseph Rizzo, MD, a Mass General Brigham ophthalmologist, found that people with diabetes who had been prescribed semaglutide were more than 4 times more likely to be diagnosed with NAION than people with diabetes who didnt take semaglutide